FMT effective for CDI in patients with cirrhosis

Fecal microbiota transplantation was safe and effective for the treatment of Clostridioides difficile infection in patients with cirrhosis, according to study results.Monika Fischer, MD, of the division of gastroenterology at Indiana University School of Medicine, and colleagues wrote that patients with cirrhosis are at higher risk for CDI due to dysbiosis, functional immunosuppression and frequent use of antibiotic therapies. However, the FMT working group has recommended against FMT for this population due to the potential for adverse events.“Hospitalized patients with cirrhosis haveRead More

Share on facebook
Share on twitter
Share on linkedin